A type of fibre that stimulates GLP-1 release approved for use in food
A form of fibre that boosts the release of the hunger-reducing hormone GLP-1 has been approved as safe by a European regulator, and could be added to foods within a year
A form of fibre that boosts the release of the hunger-reducing hormone GLP-1 has been approved as safe by a European regulator, and could be added to
Read Full Story at New Scientist →Why This Matters
This approval marks a pivotal shift in functional foods, where fiber isn’t just a nutrient but a bioactive agent altering metabolic pathways. By directly stimulating GLP-1—a hormone central to appetite regulation and glucose control—this innovation bridges the gap between dietary intervention and therapeutic nutrition, potentially redefining how obesity and diabetes are managed through everyday eating.
Background Context
GLP-1 agonists like semaglutide have transformed diabetes care, but their reliance on pharmaceutical delivery systems limits accessibility. Historically, fiber’s role in gut health has been passive; recent research, however, highlights its untapped potential to mimic drug-like effects through microbial fermentation and hormonal signaling, prompting regulatory scrutiny of such proactive applications.
What Happens Next
Food manufacturers will likely race to incorporate this fiber into products like snacks, beverages, and meal replacements, testing consumer acceptance and long-term efficacy. Regulators may soon face pressure to harmonize approval standards globally, while healthcare systems could explore reimbursement models for fortified foods as adjuncts to conventional therapies.
Bigger Picture
This development aligns with a broader convergence of nutrition and pharmacology, where food is increasingly positioned as preventative medicine. As precision nutrition gains traction, the approval of bioreactive fibers could accelerate investment in "smart foods" that target specific physiological pathways, reshaping both the food industry and public health strategies.
